8-K |
Report
| Data |
8-K |
Aug 16, 2024 |
Aug 13, 2024 |
8-K |
Report
| Data |
8-K |
Aug 9, 2024 |
Aug 8, 2024 |
10-Q |
Report
| Data |
10-Q |
Aug 8, 2024 |
Jun 30, 2024 |
8-K |
Report
| Data |
8-K |
Aug 8, 2024 |
Aug 8, 2024 |
8-K |
Report
| Data |
8-K |
Jul 19, 2024 |
Jul 19, 2024 |
8-K |
Report
| Data |
8-K |
Jun 27, 2024 |
Jun 27, 2024 |
8-K |
Report
| Data |
8-K |
Jun 11, 2024 |
Jun 10, 2024 |
8-K |
Report
| Data |
8-K |
May 22, 2024 |
May 22, 2024 |
8-K |
Report
| Data |
8-K |
May 9, 2024 |
May 8, 2024 |
10-Q |
Report
| Data |
10-Q |
May 7, 2024 |
Mar 31, 2024 |
8-K |
Report
| Data |
8-K |
May 7, 2024 |
May 7, 2024 |
8-K |
Report
| Data |
8-K |
Apr 29, 2024 |
Apr 29, 2024 |
8-K |
Report
| Data |
8-K |
Apr 29, 2024 |
Apr 29, 2024 |
8-K |
Report
| Data |
8-K |
Apr 5, 2024 |
Apr 5, 2024 |
8-K |
Report
| Data |
8-K |
Apr 1, 2024 |
Apr 1, 2024 |
10-K |
Report
| Data |
10-K |
Mar 21, 2024 |
Dec 31, 2023 |
8-K |
Report
| Data |
8-K |
Mar 21, 2024 |
Mar 21, 2024 |
SC 13G/A |
Report
|
AMENDMENT NO. 4 |
Feb 14, 2024 |
|
SC 13G |
Report
|
|
Feb 14, 2024 |
|
SC 13G/A |
Report
|
SCHEDULE 13G/A |
Feb 14, 2024 |
|
SC 13G/A |
Report
|
SC 13G/A |
Feb 13, 2024 |
|
SC 13G/A |
Report
|
|
Feb 7, 2024 |
|
SC 13G |
Report
|
|
Jan 31, 2024 |
|
SC 13G/A |
Report
|
|
Jan 16, 2024 |
|
8-K |
Report
| Data |
8-K |
Jan 8, 2024 |
Jan 8, 2024 |
SC 13G/A |
Report
|
X4 PHARMACEUTICALS, INC. |
Jan 8, 2024 |
|
8-K |
Report
| Data |
8-K |
Nov 27, 2023 |
Nov 27, 2023 |
8-K |
Report
| Data |
8-K |
Nov 14, 2023 |
Nov 13, 2023 |
10-Q |
Report
| Data |
10-Q |
Nov 9, 2023 |
Sep 30, 2023 |
8-K |
Report
| Data |
8-K |
Nov 9, 2023 |
Nov 9, 2023 |
8-K |
Report
| Data |
8-K |
Oct 31, 2023 |
Oct 31, 2023 |
8-K |
Report
| Data |
8-K |
Oct 18, 2023 |
Oct 16, 2023 |
8-K |
Report
| Data |
8-K |
Sep 5, 2023 |
Sep 5, 2023 |
10-Q |
Report
| Data |
10-Q |
Aug 10, 2023 |
Jun 30, 2023 |
8-K |
Report
| Data |
8-K |
Aug 10, 2023 |
Aug 10, 2023 |
8-K |
Report
| Data |
8-K |
Aug 3, 2023 |
Aug 2, 2023 |
SC 13G |
Report
|
|
Jun 16, 2023 |
|
8-K |
Report
| Data |
8-K |
Jun 15, 2023 |
Jun 13, 2023 |
8-K |
Report
| Data |
8-K |
Jun 1, 2023 |
Jun 1, 2023 |
SC 13D/A |
Report
|
GROWTH EQUITY OPPORTUNITIES 18 VGE, LLC / X4 PHARMACEUTICALS, INC. -- SCHEDULE 1 |
May 26, 2023 |
|
8-K |
Report
| Data |
8-K |
May 16, 2023 |
May 15, 2023 |
10-Q |
Report
| Data |
10-Q |
May 4, 2023 |
Mar 31, 2023 |
8-K |
Report
| Data |
8-K |
May 4, 2023 |
May 4, 2023 |
8-K |
Report
| Data |
8-K |
May 4, 2023 |
May 4, 2023 |
8-K |
Report
| Data |
8-K |
May 4, 2023 |
May 4, 2023 |
8-K |
Report
| Data |
8-K |
Mar 21, 2023 |
Mar 21, 2023 |
10-K |
Report
| Data |
10-K |
Mar 21, 2023 |
Dec 31, 2022 |
8-K |
Report
| Data |
8-K |
Mar 21, 2023 |
Mar 21, 2023 |
8-K |
Report
| Data |
8-K |
Mar 10, 2023 |
Mar 10, 2023 |
SC 13G/A |
Report
|
AMENDMENT NO. 3 |
Feb 14, 2023 |
|
SC 13G/A |
Report
|
SCHEDULE 13G/A, AMENDMENT #2 |
Feb 14, 2023 |
|
SC 13G/A |
Report
|
SC 13G/A |
Feb 14, 2023 |
|
SC 13G/A |
Report
|
SC 13G/A |
Feb 14, 2023 |
|
SC 13G/A |
Report
|
AMENDMENT NO. 4 TO THE SCHEDULE 13G |
Feb 14, 2023 |
|
SC 13G |
Report
|
X4 PHARMACEUTICALS, INC. |
Jan 13, 2023 |
|
8-K |
Report
| Data |
8-K |
Jan 6, 2023 |
Jan 6, 2023 |
8-K |
Report
| Data |
8-K |
Jan 5, 2023 |
Jan 5, 2023 |
8-K |
Report
| Data |
8-K |
Dec 23, 2022 |
Dec 20, 2022 |
SC 13D/A |
Report
|
GROWTH EQUITY OPPORTUNITIES 18 VGE, LLC / X4 PHARMACEUTICALS, INC. -- SCHEDULE 1 |
Dec 20, 2022 |
|
8-K |
Report
| Data |
8-K |
Dec 9, 2022 |
Dec 6, 2022 |
8-K |
Report
| Data |
8-K |
Nov 29, 2022 |
Nov 29, 2022 |
8-K |
Report
| Data |
8-K |
Nov 9, 2022 |
Nov 7, 2022 |
10-Q |
Report
| Data |
10-Q |
Nov 3, 2022 |
Sep 30, 2022 |
8-K |
Report
| Data |
8-K |
Nov 3, 2022 |
Nov 3, 2022 |
8-K |
Report
| Data |
8-K |
Oct 4, 2022 |
Oct 4, 2022 |
8-K |
Report
| Data |
8-K |
Sep 27, 2022 |
Sep 27, 2022 |
8-K |
Report
| Data |
8-K |
Sep 1, 2022 |
Sep 1, 2022 |
8-K |
Report
| Data |
8-K |
Aug 5, 2022 |
Aug 5, 2022 |
10-Q |
Report
| Data |
10-Q |
Aug 4, 2022 |
Jun 30, 2022 |
8-K |
Report
| Data |
8-K |
Aug 4, 2022 |
Aug 4, 2022 |
8-K |
Report
| Data |
8-K |
Jul 29, 2022 |
Jul 25, 2022 |
SC 13D |
Report
|
GROWTH EQUITY OPPORTUNITIES 18 VGE, LLC / X4 PHARMACEUTICALS, INC. -- SCHEDULE 1 |
Jul 19, 2022 |
|
8-K |
Report
| Data |
8-K |
Jul 1, 2022 |
Jun 30, 2022 |
8-K |
Report
| Data |
8-K |
Jun 7, 2022 |
Jun 6, 2022 |
8-K |
Report
| Data |
8-K |
May 20, 2022 |
May 20, 2022 |
10-Q |
Report
| Data |
10-Q |
May 12, 2022 |
Mar 31, 2022 |
8-K |
Report
| Data |
8-K |
May 12, 2022 |
May 12, 2022 |
10-K |
Report
| Data |
10-K |
Mar 17, 2022 |
Dec 31, 2021 |
8-K |
Report
| Data |
8-K |
Mar 17, 2022 |
Mar 17, 2022 |
8-K |
Report
| Data |
8-K |
Mar 3, 2022 |
Mar 3, 2022 |
SC 13G/A |
Report
|
SC 13G/A |
Feb 14, 2022 |
|
SC 13G/A |
Report
|
SCHEDULE 13G (AMENDMENT NO. 1) |
Feb 14, 2022 |
|
SC 13G/A |
Report
|
X4 PHARMACEUTICALS, INC |
Feb 14, 2022 |
|
SC 13G/A |
Report
|
AMENDMENT NO. 3 TO THE SCHEDULE 13G |
Feb 14, 2022 |
|
SC 13G/A |
Report
|
SC 13G/A |
Feb 14, 2022 |
|
SC 13G/A |
Report
|
AMENDMENT NO. 2 |
Feb 11, 2022 |
|
SC 13G/A |
Report
|
|
Feb 11, 2022 |
|
8-K |
Report
| Data |
8-K |
Feb 9, 2022 |
Feb 9, 2022 |
8-K/A |
Report
| Data |
8-K/A |
Jan 26, 2022 |
Jan 25, 2022 |
8-K |
Report
| Data |
8-K |
Jan 25, 2022 |
Jan 25, 2022 |
SC 13G |
Report
|
SC 13G |
Jan 19, 2022 |
|
8-K |
Report
| Data |
8-K |
Jan 14, 2022 |
Jan 14, 2022 |
8-K |
Report
| Data |
8-K |
Jan 14, 2022 |
Jan 13, 2022 |
8-K |
Report
| Data |
8-K |
Dec 13, 2021 |
Dec 13, 2021 |
SC 13G |
Report
|
SCHEDULE 13G |
Nov 17, 2021 |
|
8-K |
Report
| Data |
8-K |
Nov 15, 2021 |
Nov 15, 2021 |
8-K |
Report
| Data |
8-K |
Nov 12, 2021 |
Nov 11, 2021 |
8-K |
Report
| Data |
8-K |
Nov 5, 2021 |
Nov 5, 2021 |
10-Q |
Report
| Data |
10-Q |
Nov 4, 2021 |
Sep 30, 2021 |
8-K |
Report
| Data |
8-K |
Nov 4, 2021 |
Nov 4, 2021 |
8-K |
Report
| Data |
8-K |
Oct 19, 2021 |
Oct 14, 2021 |
8-K |
Report
| Data |
8-K |
Sep 10, 2021 |
Sep 10, 2021 |
8-K |
Report
| Data |
8-K |
Aug 6, 2021 |
Aug 6, 2021 |
10-Q |
Report
| Data |
10-Q |
Aug 3, 2021 |
Jun 30, 2021 |
8-K |
Report
| Data |
8-K |
Aug 3, 2021 |
Aug 3, 2021 |
8-K |
Report
| Data |
8-K |
Jul 23, 2021 |
Jul 20, 2021 |
8-K |
Report
| Data |
8-K |
Jul 15, 2021 |
Jul 15, 2021 |
SC 13G |
Report
|
ACQUISITION OF BENEFICIAL OWNERSHIP |
Jun 29, 2021 |
|
8-K |
Report
| Data |
8-K |
Jun 28, 2021 |
Jun 28, 2021 |
8-K |
Report
| Data |
8-K |
Jun 11, 2021 |
Jun 11, 2021 |
8-K |
Report
| Data |
8-K |
Jun 7, 2021 |
Jun 7, 2021 |
SC 13G/A |
Report
|
|
May 7, 2021 |
|
8-K |
Report
| Data |
8-K |
May 6, 2021 |
May 6, 2021 |
10-Q |
Report
| Data |
10-Q |
May 6, 2021 |
Mar 31, 2021 |
8-K |
Report
| Data |
8-K |
Apr 9, 2021 |
Apr 9, 2021 |
SC 13G/A |
Report
|
SC 13G/A |
Apr 8, 2021 |
|
SC 13G/A |
Report
|
AMENDMENT NO. 1 |
Mar 25, 2021 |
|
10-K |
Report
| Data |
10-K |
Mar 19, 2021 |
Dec 31, 2020 |
8-K |
Report
| Data |
8-K |
Mar 19, 2021 |
Mar 18, 2021 |
8-K |
Report
| Data |
8-K |
Mar 4, 2021 |
Mar 4, 2021 |
SC 13G/A |
Report
|
SC 13G/A |
Feb 16, 2021 |
|
SC 13G/A |
Report
|
SC 13G/A |
Feb 16, 2021 |
|
SC 13G/A |
Report
|
AMENDMENT NO. 2 TO THE SCHEDULE 13G |
Feb 16, 2021 |
|
SC 13G/A |
Report
|
|
Feb 16, 2021 |
|
SC 13G/A |
Report
|
|
Feb 12, 2021 |
|
SC 13G |
Report
|
|
Feb 2, 2021 |
|
8-K |
Report
| Data |
8-K |
Jan 8, 2021 |
Jan 8, 2021 |
SC 13G |
Report
|
SC 13G |
Dec 30, 2020 |
|
8-K |
Report
| Data |
8-K |
Dec 23, 2020 |
Dec 21, 2020 |
10-Q |
Report
| Data |
10-Q |
Nov 5, 2020 |
Sep 30, 2020 |
8-K |
Report
| Data |
8-K |
Nov 5, 2020 |
Nov 5, 2020 |
8-K |
Report
| Data |
8-K |
Oct 16, 2020 |
Oct 14, 2020 |
8-K |
Report
| Data |
8-K |
Oct 7, 2020 |
Oct 7, 2020 |
8-K |
Report
| Data |
8-K |
Oct 1, 2020 |
Sep 25, 2020 |
8-K |
Report
| Data |
8-K |
Sep 11, 2020 |
Sep 11, 2020 |
SC 13G/A |
Report
|
|
Sep 10, 2020 |
|
10-Q |
Report
| Data |
10-Q |
Aug 4, 2020 |
Jun 30, 2020 |
8-K |
Report
|
8-K |
Jul 30, 2020 |
Jul 29, 2020 |
8-K |
Report
|
8-K |
Jun 11, 2020 |
Jun 10, 2020 |
10-Q |
Report
| Data |
10-Q |
May 7, 2020 |
Mar 31, 2020 |
8-K |
Report
|
8-K |
May 7, 2020 |
May 6, 2020 |
8-K |
Report
|
8-K |
Mar 20, 2020 |
Mar 18, 2020 |
8-K |
Report
|
8-K |
Mar 17, 2020 |
Mar 13, 2020 |
10-K |
Report
| Data |
10-K |
Mar 12, 2020 |
Dec 31, 2019 |
8-K |
Report
|
8-K |
Mar 12, 2020 |
Mar 6, 2020 |
SC 13G/A |
Report
|
AMENDMENT NO. 1 TO THE SCHEDULE 13G |
Feb 14, 2020 |
|
SC 13G |
Report
|
SCHEDULE 13G |
Feb 14, 2020 |
|
SC 13G/A |
Report
|
|
Feb 14, 2020 |
|
SC 13G/A |
Report
|
|
Feb 14, 2020 |
|
8-K |
Report
|
8-K |
Feb 13, 2020 |
Feb 10, 2020 |
SC 13G/A |
Report
|
|
Feb 13, 2020 |
|
8-K |
Report
|
8-K |
Jan 10, 2020 |
Jan 9, 2020 |
SC 13G |
Report
|
|
Dec 17, 2019 |
|
SC 13G |
Report
|
SC 13G |
Dec 9, 2019 |
|
SC 13G/A |
Report
|
|
Dec 3, 2019 |
|
8-K |
Report
|
8-K |
Nov 27, 2019 |
Nov 25, 2019 |
8-K |
Report
|
8-K |
Nov 14, 2019 |
Nov 14, 2019 |
10-Q |
Report
| Data |
10-Q |
Nov 7, 2019 |
Sep 30, 2019 |
8-K |
Report
|
8-K |
Nov 7, 2019 |
Nov 7, 2019 |
8-K/A |
Report
|
8-K/A |
Oct 18, 2019 |
Sep 18, 2019 |
8-K |
Report
|
8-K |
Oct 4, 2019 |
Oct 3, 2019 |
8-K |
Report
|
8-K |
Sep 30, 2019 |
Sep 30, 2019 |
8-K |
Report
|
8-K |
Sep 20, 2019 |
Sep 18, 2019 |
8-K |
Report
|
8-K |
Aug 9, 2019 |
Aug 9, 2019 |
10-Q |
Report
| Data |
10-Q |
Aug 7, 2019 |
Jun 30, 2019 |
SC 13D/A |
Report
|
SC 13D/A |
Jul 17, 2019 |
|
8-K |
Report
|
8-K |
Jun 28, 2019 |
Jun 27, 2019 |
8-K |
Report
|
8-K |
Jun 26, 2019 |
Jun 26, 2019 |
8-K |
Report
|
8-K |
Jun 19, 2019 |
Jun 17, 2019 |
SC 13D/A |
Report
|
NEW ENTERPRISE ASSOCIATES 16, L.P. - X4 PHARMACEUTICALS, INC. 13D/A1 |
May 28, 2019 |
|
8-K/A |
Report
|
8-K/A |
May 17, 2019 |
Mar 29, 2019 |
10-Q |
Report
| Data |
10-Q |
May 15, 2019 |
Mar 31, 2019 |
8-K/A |
Report
|
8-K/A |
May 13, 2019 |
Mar 11, 2019 |
SC 13G |
Report
|
|
May 10, 2019 |
|
SC 13D/A |
Report
|
SC 13D/A |
Apr 26, 2019 |
|
SC 13G |
Report
|
THE SCHEDULE 13G |
Apr 23, 2019 |
|
SC 13G |
Report
|
|
Apr 22, 2019 |
|
SC 13G |
Report
|
SCHEDULE 13G |
Apr 19, 2019 |
|
SC 13G |
Report
|
|
Apr 16, 2019 |
|
8-K |
Report
|
8-K |
Apr 15, 2019 |
Apr 12, 2019 |
8-K |
Report
|
8-K |
Apr 12, 2019 |
Apr 11, 2019 |
8-K |
Report
|
FORM 8-K |
Apr 11, 2019 |
Apr 11, 2019 |
8-K/A |
Report
|
8-K/A |
Apr 3, 2019 |
Mar 11, 2019 |
8-K |
Report
|
FORM 8-K |
Apr 2, 2019 |
Mar 29, 2019 |
8-K |
Report
|
8-K |
Apr 1, 2019 |
Apr 1, 2019 |
SC 13D |
Report
|
SC 13D |
Mar 22, 2019 |
|
SC 13D/A |
Report
|
AMENDMENT NO. 2 |
Mar 19, 2019 |
|
SC 13G |
Report
|
|
Mar 15, 2019 |
|
8-K |
Report
|
8-K |
Mar 13, 2019 |
Mar 11, 2019 |
10-K |
Report
| Data |
10-K |
Mar 11, 2019 |
Dec 31, 2018 |
8-K |
Report
|
8-K |
Mar 8, 2019 |
Mar 8, 2019 |
8-K |
Report
|
8-K |
Mar 1, 2019 |
Feb 25, 2019 |
8-K |
Report
|
8-K |
Feb 8, 2019 |
Feb 4, 2019 |
8-K |
Report
|
8-K |
Jan 16, 2019 |
Jan 11, 2019 |
8-K |
Report
|
8-K |
Dec 20, 2018 |
Dec 12, 2018 |
SC 13D |
Report
|
SCHEDULE 13D |
Dec 6, 2018 |
|
8-K |
Report
|
8-K |
Nov 27, 2018 |
Nov 27, 2018 |
8-K |
Report
|
8-K |
Nov 27, 2018 |
Nov 26, 2018 |
10-Q |
Report
| Data |
10-Q |
Nov 9, 2018 |
Sep 30, 2018 |
8-K |
Report
|
8-K |
Nov 9, 2018 |
Nov 9, 2018 |
SC 13G/A |
Report
|
|
Oct 10, 2018 |
|
10-Q |
Report
| Data |
10-Q |
Aug 13, 2018 |
Jun 30, 2018 |
8-K |
Report
|
8-K |
Aug 13, 2018 |
Aug 13, 2018 |
SC 13G/A |
Report
|
|
Aug 10, 2018 |
|
8-K |
Report
|
FORM 8-K |
Jun 28, 2018 |
Jun 28, 2018 |
8-K |
Report
|
8-K |
Jun 12, 2018 |
Jun 6, 2018 |
8-K |
Report
|
8-K |
Jun 7, 2018 |
Jun 5, 2018 |
10-Q |
Report
| Data |
10-Q |
May 10, 2018 |
Mar 31, 2018 |
8-K |
Report
|
8-K |
May 10, 2018 |
May 10, 2018 |
10-K |
Report
|
10-K |
Mar 9, 2018 |
Dec 31, 2017 |
8-K |
Report
|
8-K |
Mar 9, 2018 |
Mar 9, 2018 |
SC 13D |
Report
|
SC 13D |
Feb 14, 2018 |
|
SC 13G |
Report
|
|
Feb 13, 2018 |
|
SC 13G/A |
Report
|
|
Feb 13, 2018 |
|
SC 13D/A |
Report
|
AMENDMENT NO. 1 |
Jan 26, 2018 |
|
SC 13G |
Report
|
|
Dec 11, 2017 |
|
SC 13D |
Report
|
SCHEDULE 13D |
Nov 30, 2017 |
|
SC 13D |
Report
|
SC 13D |
Nov 29, 2017 |
|
SC 13D |
Report
|
NEW ENTERPRISE ASSOCIATES 16, L.P. - ARSANIS, INC. 13D |
Nov 29, 2017 |
|
8-K |
Report
|
8-K |
Nov 20, 2017 |
Nov 20, 2017 |